Swedencare AB (publ) announce new CEO after strategic acquisition

Report this content

The Board of Directors of Swedencare AB (publ) have today assigned Håkan Lagerberg to new CEO, former CEO Jenny Graflind will at the same time return as Group CFO

Håkan Lagerberg assumes his position as CEO today, on June 24th.

The background to the management changes is the strategic acquisition announced earlier today.

“My board colleagues and I want to thank Jenny for a job well done as CEO during a period where the focus was on expanding the market initiatives around the ProDen PlaqueOff® product family. As we now carry out a strategic acquisition and at the same time continue to evaluate further acquisitions, we are pleased to welcome Håkan back as CEO while with Jenny as CFO ensuring a strong financial control function. With Håkan and Jenny in Group Management and a strategically important acquisition completed, we look forward to continuing to develop Swedencare into the leading global animal health company with a growing product portfolio.” says Per Malmström, Chairman of the Board of Swedencare.

“With the acquisition we are gearing up and need to strengthen both operationally and financially. With my financial background and the experience of working for several years in the US in finance functions, I look forward to working with our new American subsidiary and our larger, stronger and broader group." says Jenny Graflind, departing CEO.

“I am grateful to have the chance of coming back into an operational role as I see many new and exciting opportunities with the acquisition of Stratford's operations which we are now carrying out. A prerequisite for me to accept the offer was that Jenny also thought it was a good and exciting challenge to work together again. We are an excellent team and complement each other perfectly, something that is needed now as we accelerate the pace of Swedencare's development. I have also been in contact with Stratford's MD, Brian Nugent, since 2018, and I am convinced that he and his team will be a decisive factor for us reaching or perhaps even exceeding our recently set financial targets." says Håkan Lagerberg, incoming CEO.

For more information, please contact:

Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 0170
Email: hakan.lagerberg@swedencare.se

Per Malmström, Chairman of the Board
Phone: 46 (0)70 725 28 36

Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 8554
Email: jenny.graflind@swedencare.se

FNCA Sweden AB is the Certified Adviser of the Company
Phone: +46 (0)8 528 00 399  Email: info@fnca.se

Please visit the Company homepage www.swedencare.se



About Swedencare 

Swedencare develop, produce, market, and sell premium products on the global and fast-growing market within animal healthcare for cats, dogs and horses. The product groups ProDen PlaqueOff and NutriScience are represented on approximately fifty markets in all parts of the world, including the headquarter in Malmö, seven subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland and through an external distribution network.  Swedencare’s sales have increased significantly over the last few years with strong margins and results.  The board of directors and the management have a wide and extensive experience of international marketing and sales.

This is information that Swedencare AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 5:32 p.m. CET on June 24th, 2020.

Documents & Links

Quotes

My board colleagues and I want to thank Jenny for a job well done as CEO during a period where the focus was on expanding the market initiatives around the ProDen PlaqueOff® product family. As we now carry out a strategic acquisition and at the same time continue to evaluate further acquisitions, we are pleased to welcome Håkan back as CEO while with Jenny as CFO ensuring a strong financial control function. With Håkan and Jenny in Group Management and a strategically important acquisition completed, we look forward to continuing to develop Swedencare into the leading global animal health company with a growing product portfolio.
Per Malmström, Chairman of the Board of Swedencare
With the acquisition we are gearing up and need to strengthen both operationally and financially. With my financial background and the experience of working for several years in the US in finance functions, I look forward to working with our new American subsidiary and our larger, stronger and broader group.
Jenny Graflind, departing CEO
I am grateful to have the chance of coming back into an operational role as I see many new and exciting opportunities with the acquisition of Stratford's operations which we are now carrying out. A prerequisite for me to accept the offer was that Jenny also thought it was a good and exciting challenge to work together again. We are an excellent team and complement each other perfectly, something that is needed now as we accelerate the pace of Swedencare's development. I have also been in contact with Stratford's MD, Brian Nugent, since 2018, and I am convinced that he and his team will be a decisive factor for us reaching or perhaps even exceeding our recently set financial targets.
Håkan Lagerberg, incoming CEO